To support the clinical application of CAR-T therapy for CNS-MM, here, we reported a case study of BCMA CAR-T in an MM patient with severe cytogenetic abnormalities and multiple extramedullary infiltration sites including CNS invasion. This evidence concerns the gene TNFRSF17 and Miyoshi myopathy.